期刊文献+

268例子宫内膜癌淋巴结转移相关因素分析 被引量:7

Analysis of the Related Factors of Lymph Node Metastasis in 268 Cases of Endometrial Carcinoma
下载PDF
导出
摘要 目的:探讨影响子宫内膜癌淋巴结转移的相关因素,为制定手术方案提供依据。方法:收集经病理学证实的268例子宫内膜癌患者的临床病理资料并进行回顾性分析。根据患者淋巴结转移情况分为淋巴结转移阳性组和阴性组,分析2组肌层浸润、病理类型、宫旁受累情况、分化程度、年龄、腹腔细胞学结果及血清CA125水平的异同,并对上述指标与淋巴结转移之间的关系进行分析。结果:268例子宫内膜癌的淋巴结转移率为10.07%(27/268),主要转移至髂外淋巴结和闭孔淋巴结(占81.48%),腹主动脉旁淋巴结转移率为9.68%(6/62)。淋巴结转移率在深肌层浸润、非内膜样癌、中分化和低分化内膜样癌、累及宫颈或宫旁组织、血清CA125水平升高及年龄≥60岁的患者均分别显著高于无肌层和浅肌层浸润、子宫内膜样癌、高分化内膜样癌、仅限于宫腔内、血清CA125水平正常及年龄<60岁的患者(均P<0.01),而腹腔细胞学阳性与阴性者淋巴结转移率差异无统计学意义。多因素分析结果表明内膜样癌分化程度、肌层浸润和血清CA125水平是淋巴结转移的影响因素(均P<0.05)。结论:深肌层浸润、中低分化子宫内膜样癌和较高的血清CA125水平可作为淋巴结转移的高危因素。 Objective: To investigate the related clinical and pathological factors of lymph node metastasis in patients with endometrial carcinoma. Methods: A total of 268 patients with histological confirmed endometrial carcinoma were selected and retrospectively analysed. Patients were divided into two groups on the basis of positive or negative lymph nodes metastasis. The differences of the following parameters were compared between two groups, including depth of myometrial invasion, pathological type, para-uterus invasion, differential degree of endometrioid carcinoma, age, the result of abdominal cytology and serum CA125 level. Simultaneously, the correlation between the above parameters and lymph node metastasis were analyzed. Results: The lymph node metastasis rate was 10.07% (27/268) in 268 patients. The external iliac and obturator lymph nodes were the preferred sites, which took up about 81.48%. The abdominal aorta lymph node metastasis rate was 9.68% (6/62). The metastasis rates were significantly higher in patients with deep myometrial invasion, non- endometrioid adenocareinoma, middle and poorly differentiated tumor, para-uterus invasion, higher abnormal serum CA125 level and age ≥60 than those of patients with non or superficial myometrial invasion, endometrioid adenocarcinoma, well differentiated tumor, without para-uterus invasion, normal serum CA125 level and age〈60 (P 〈 0.01 for all), respectively. There was no significant difference in the lymph node metastasis rate between patients with positive and negative abdominal cytology detection. The logistic regression analysis showed that the degree of endometrioid adenocarcinoma differentiation, myometrial invasion and serum CA125 level were correlated with lymph node metastasis. Conclusion: The high-risk factors of lymph node metastasis were deep myometrial invasion, middle and poorly differentiated tumor and elevated serum CA125 level in patients with endometrial cancer.
作者 李艳 岳天孚
出处 《天津医药》 CAS 北大核心 2012年第10期998-1001,共4页 Tianjin Medical Journal
关键词 子宫内膜肿瘤 淋巴转移 淋巴细胞 肿瘤浸润 CA-125抗原 危险因素 病理学 临床 回顾性研究 endometrial neoplasms lymphatic metastasis lymphocytes, tumor-infiltrating CA-125 antigen risk factors pathology, clinical retrospective studies
  • 相关文献

参考文献10

  • 1程红,戴林,郭双平,等.译.乳腺及女性生殖器官肿瘤病理学和遗传学[M].北京:人民卫生出版社,2006.189
  • 2Pecorelli S. Revised FIGO staging for carcinoma of the vulva,cervix, and endometrium[J].Int J of Gynecol Oncol, 2009, 105(2):103-104.
  • 3王仲兰,高企贤.恶性肿瘤在妇科疾病死亡中的地位[J].天津医药,2002,30(11):687-688. 被引量:2
  • 4ASTEC study group, Kitchener H, Swart AM, et al. Efficacy ofsystemtic pelvic lymphadenectomy in endometrial cancer (MRCASTEC trial): a randomized study [J].Lancet,2009, 373 (9658):125-136.
  • 5Convery PA, Cantrell LA, Di Santo N, et al. Retrospective review ofan intraoperative algorithm to predict lymph node metastasis inlow -grade endometrial adenocarcinoma [J].Gynecol Oncol ,2011,123(1):65-70.
  • 6Toshio F, Jun F,Toshinobu T, et al. Role of complete para-aorticlymphaden - ectomy in endometrial cancer [J].Cuit Opin ObstetGynecol,2009, 21(1): 10-14.
  • 7王利君,王武亮,袁博,毛丽丽,徐臻.腹主动脉旁淋巴结切除在子宫内膜癌手术治疗中的意义[J].实用妇产科杂志,2011,27(11):845-847. 被引量:9
  • 8Hidenori T, Hirokazu S, Hiroshi M, et al. Can we omit para-aortalymph node dissection in endometrial cancer[J]/ Jpn J Clin Oncol,2006,36(9): 578-581.
  • 9Hidaka T, Nakashima A, Shima T, et al. Systemic lymphaden 一ectomy cannot be recommended for low -risk corpus cancer [J].Obstet Gynecol Int,2010,2010:490219.
  • 10Han SS,Lee SH, Kim DH, et al. Evaluation of preoperative criteriaused to predict lymph node metastasis in endometrial cancer [J].Acta Obstet Gynecol Scand,2010,89(2): 168-174.

二级参考文献13

  • 1曹泽毅.中华妇产科学(第1版)[M].北京:人民卫生出版社,1999.35-37.
  • 2Robova H, Charvat M, Stmad P, et al. Lymphatic mappingin endometrial cancer: comparison of hysteroscopic andsubserosal injection and the distribution of sentinel lymphnodes [ J]. Int J Gynecol Cancer, 2009, 19(3) :391 -394.
  • 3Maggino T, Romagnolo C, Landoni F, et al. An analysis of approaches to the management of endometrial cancer in North America: a CTF study[ J ]. Gynecol Oncol, 1998,68 (3) : 274 - 279.
  • 4Maggino T, Romagnolo C, Zola P, et al. An analysis of approaches to the treatment of endometrial cancer in western Europe : a CTF study [J]. Eur J Cancer,1995, 31A(12) : 1993 - 1997.
  • 5Kitchener H, Redman CW, Swart AM, et al. A randomised trial of lymphadenectomy in the treatment of endometrial cancer[ J]. Gynecol Oncol, 2006, 101 ( Suppll ) :S21 - S22.
  • 6Aalders JG, Thomas G. Endometrial cancer-revisiting the importance of pelvic and para aortic lymph nodes [ J ]. Gynecol Oncol, 2007, 104(1) :222 -231.
  • 7Pristauz G, Bader AA, Regitnig P, et al. How accurate is frozen section histology of pelvic lymph nodes in patients with endometrial cancer[J]. GynecolOncol, 2009, 115(1):12 -17.
  • 8Selman TJ, Mann CH, Zamora J, et al. A systematic review of tests for lymph node status in primary endometrial cancer [ J ]. BMC Womens Health, 2008, 8( 1 ) :8.
  • 9Fotiou S, Trimble EL, Papakonstantinou K, et al. Complete pelvic lymphadenectomy in patients with clinical early, grade I and II endometrioid corpus cancer [ J ]. Anticancer Res, 2009, 29 ( 7 ) : 2781 - 2785.
  • 10Hunn J, Dodson MK, Webb J, et al. Endometrial cancer current state of the art therapies and unmet clinical needs : the role of surgery and preoperative radiographic assessment [ J ]. Adv Drug Deliv Rev, 2009, 61(10) : 890-895.

共引文献12

同被引文献58

  • 1Sorbe B, Juresta C, Ahlin C. Natural history of recurrences in endometfial carcinoma [ J ]. Oncol Lett, 2014, 8 (4) : 1800- 1806.
  • 2Euscher E, Fox P, Bassett R, et al. The pattern of myometrial invasion as a predictor of lymph node metastasis or extrauterine disease in low-grade endometrial carcinoma [ J ]. Am J Surg Pathol, 2013, 37(11 ): 1728-1736.
  • 3Nikolaou M, Kourea HP, Tzelepi V, et al. The prognostic role of preoperative serum CA 125 levels in patients with endometrial carcinoma[J]. J BUON, 2014, 19(1) : 198-202.
  • 4Cetinkaya K, Atalay F, Baeinoglu A. Risk factors of lymph node metastases with endometrial carcinoma[J]. Asian Pac J Cancer Prey, 2014, 15(15) : 6353-6356.
  • 5Kim CH, Soslow RA, Park K J, et al. Pathologic ultrastaging im- proves micrometastasis detection in sentinel lymph nodes during endometrial cancer staging[ J]. Int J Gynecol Cancer, 2013, 23 (5) : 964-970.
  • 6Sciallis AP, Bedroske PP, Schoolmeester JK, et al. High-grade endometrial stromal sarcomas: a clinicopathologic study of a group of tumors with heterogenous morphologic and genetic fea- tures[J]. Am J Surg Pathol, 2014, 38(9) : 1161-1172.
  • 7Patsner B, Yim GW. Predictive value of preoperative serum CA- 125 levels in patients with uterine cancer: The Asian experience 2000 to 2012[J]. Obstet Gynecol Sci, 2013, 56(5) : 281-288.
  • 8Jung IK, Kim SS, Suh DS. Tumor-infiltration of T-lymphocytes is inversely correlated with clinicopathologic factors in endometrial adenocarcinoma[J]. Obstet Gynecol Sci, 2014, 57 (4): 266- 273.
  • 9Cusido M, Fargas F, Rodrlguez I, et al. Role of lymphade- nectomy in endometrioid endometrial cancer [ J ]. Eur J Gynaecol Onco1,2011,32 ( 1 ) :49.
  • 10Horvaith K,Pete I,Vereczkey I, et al. Evaluation of the ac- curacy of preoperative MRI in measuring myometrial infil- tration in endometrial carcinoma [ J ]. Pathol Oncol Res, 2014,20(2) :327.

引证文献7

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部